Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-15T10:39:39.544Z Has data issue: false hasContentIssue false

13 - Screening, detection and survival patterns of breast and other cancers in high-risk families

Published online by Cambridge University Press:  24 August 2009

Pål Møller
Affiliation:
The Norwegian Radium Hospital, Oslo, Norway
C. Michael Steel
Affiliation:
The Norwegian Radium Hospital, Oslo, Norway
Patrick J. Morrison
Affiliation:
Belfast City Hospital, Belfast
Shirley V. Hodgson
Affiliation:
Guy's Hospital, London
Neva E. Haites
Affiliation:
University of Aberdeen
Get access

Summary

Background

Untreated inherited breast cancer is recognized as a lethal disorder. The first detailed description in modern literature is probably ‘Family Z’, reported by Broca in 1866. If interpreting ‘liver cancer’ as ovarian cancer with spread, Broca described a family with dominantly inherited breast/ovarian cancer syndrome causing early death, and concluded that the cause had to be genetic factors with sex-limited phenotypic expression. He also discussed the putative impact of modifying genetic and environmental factors on the penetrance and expression of the major mutations, which may be discouraging for those who claim to have discovered new insights lately. More than 100 years later, it was agreed that inherited breast cancer was not rare (Iselius et al., 1992). In this chapter, the term ‘inherited’ is used for monogenic inheritance with high penetrance. Recessive or X-linked inherited breast cancer has not been described. The postulated category of inherited breast cancer caused by more frequent mutations with lower penetrance has yet to be defined precisely, and is outside the scope of this chapter. Thus, ‘inherited breast cancer’ denotes dominant inheritance, as indicated by family history or demonstrated mutation. BRCA1, BRCA2, PTEN, TP53 and other genes do, when mutated, cause inherited breast cancer. All mutations proven to cause breast cancer also increase the risk of other cancer(s) (Lynch et al., 1997; Johansson et al., 1999; Chompret et al., 2000).

Type
Chapter
Information
Familial Breast and Ovarian Cancer
Genetics, Screening and Management
, pp. 204 - 219
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×